CH
Chris Howerton Jefferies Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ardelyx
ARDX
$1.59B
| $6.59 | $8 |
21%
upside
| Buy |
2 Jan ‘25
8 months ago |
|
2
Structure Therapeutics
GPCR
$1.22B
| $21.17 | $79 |
273%
upside
| Buy |
29 Sep ‘23
1 year ago |
|
3
Milestone Pharmaceuticals
MIST
$150M
| $1.77 | $4 |
126%
upside
| Hold |
20 Jun ‘23
2 years ago |
|
4
Veru
VERU
$49.1M
| $3.35 | $10 |
199%
upside
| Hold |
7 Jun ‘23
2 years ago |
|
5
BioXcel Therapeutics
BTAI
$60.4M
| $4.15 | $352 |
8,382%
upside
| Hold |
10 Mar ‘23
2 years ago |
|
6
Avalo Therapeutics
AVTX
$150M
| $11.44 | $720 |
6,194%
upside
| Underperform |
8 Feb ‘23
2 years ago |
|
7
Compugen
CGEN
$135M
| $1.44 | $0.5000 |
65%
downside
| Underperform |
8 Feb ‘23
2 years ago |
|
8
UroGen Pharma
URGN
$964M
| $20.84 | $10 |
52%
downside
| Hold |
8 Feb ‘23
2 years ago |
|
9
MEI Pharma
MEIP
$98.5M
| $3 | $2 |
33%
downside
| Underperform |
8 Feb ‘23
2 years ago |
|
|
AVDL
10
Avadel Pharmaceuticals
AVDL
$1.5B
| $15.45 | $11 |
29%
downside
| Buy |
30 Nov ‘22
2 years ago |
|
11
Apellis Pharmaceuticals
APLS
$3.4B
| $26.91 | $40 |
49%
upside
| Hold |
10 Nov ‘22
2 years ago |
|
12
Harmony Biosciences
HRMY
$2.07B
| $36.02 | $61 |
69%
upside
| Buy |
14 Oct ‘22
2 years ago |
|
13
Axsome Therapeutics
AXSM
$6.4B
| $128.19 | $90 |
30%
downside
| Buy |
30 Sep ‘22
2 years ago |
|
14
Disc Medicine
IRON
$2.17B
| $62.30 | $1.50 |
98%
downside
| Hold |
1 Mar ‘22
3 years ago |
|
15
Vanda Pharmaceuticals
VNDA
$271M
| $4.58 | $12 |
162%
upside
| Hold |
25 Feb ‘22
3 years ago |
|
16
IO Biotech
IOBT
$119M
| $1.81 | $20 |
1,005%
upside
| Buy |
30 Nov ‘21
3 years ago |
|
17
Celldex Therapeutics
CLDX
$1.58B
| $23.77 | $66 |
178%
upside
| Buy |
17 Sep ‘21
4 years ago |
|
18
Candel Therapeutics
CADL
$281M
| $5.11 | $22 |
331%
upside
| Buy |
23 Aug ‘21
4 years ago |
|
19
TScan Therapeutics
TCRX
$105M
| $1.85 | $21 |
1,035%
upside
| Buy |
10 Aug ‘21
4 years ago |
|
20
Werewolf Therapeutics
HOWL
$61.3M
| $1.34 | $22 |
1,542%
upside
| Buy |
25 May ‘21
4 years ago |
|
21
LAVA Therapeutics
LVTX
$40.5M
| $1.54 | $23 |
1,394%
upside
| Buy |
19 Apr ‘21
4 years ago |
|
22
Acadia Pharmaceuticals
ACAD
$4.31B
| $25.55 | $21 |
18%
downside
| Hold |
6 Apr ‘21
4 years ago |
|
23
Alaunos Therapeutics
TCRT
$4.43M
| $2.24 | $5 |
123%
upside
| Hold |
12 Mar ‘21
4 years ago |
|
24
Pluri
PLUR
$36M
| $4.58 | $6 |
31%
upside
| Hold |
10 Dec ‘20
4 years ago |
|
25
Seres Therapeutics
MCRB
$209M
| $23.85 | $580 |
2,332%
upside
| Buy |
11 Aug ‘20
5 years ago |
|